SrRan 1 g/day | SrRan 2 g/day | Placebo | P -value | Placebo versus SrRan 1 g/day | Placebo versus SrRan 2 g/day | |
---|---|---|---|---|---|---|
n = 19 | n = 15 | n = 26 | P -value | P -value | ||
Joint space width loss | ||||||
mm | -0.46 ± 0.45 | -0.41 ± 0.42 | -0.76 ± 0.67 | 0.085* | ||
% | -18.54 ± 19.69 | -14.67 ± 15.69 | -23.24 ± 19.23 | 0.228* | ||
MRI (%) | ||||||
Global knee | -7.66 ± 2.10 | -6.67 ± 2.56 | -8.02 ± 3.28 | 0.351* | ||
Femur | -7.70 ± 2.66 | -6.98 ± 4.26 | -7.28 ± 2.91 | 0.809* | ||
Plateau | -7.61 ± 3.79 | -5.74 ± 3.54 | -10.01 ± 5.79 | 0.003* | 0.070** | 0.007** |
Medial compartment | -10.29 ± 3.68 | -9.14 ± 3.27 | -10.40 ± 4.23 | 0.119* | ||
Medial femur | -11.17 ± 4.25 | -10.72 ± 5.36 | -10.89 ± 3.19 | 0.290* | ||
Medial plateau | -8.13 ± 5.98 | -4.90 ± 5.19 | -9.07 ± 8.74 | 0.048* | 0.708** | 0.081** |